XML 51 R40.htm IDEA: XBRL DOCUMENT v3.22.2
Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details) - USD ($)
$ in Millions
3 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Restructuring Reserve [Roll Forward]    
Beginning balance $ 130  
Restructuring, impairment, and related charges 23 $ 158
Non-cash charges 0  
Cash payments (22)  
Other (15)  
Ending balance 116  
Operating Segments | U.S. Pharmaceutical    
Restructuring Reserve [Roll Forward]    
Beginning balance 11  
Restructuring, impairment, and related charges 4 12
Non-cash charges 0  
Cash payments (2)  
Other (1)  
Ending balance 12  
Operating Segments | Prescription Technology Solutions    
Restructuring Reserve [Roll Forward]    
Beginning balance 3  
Restructuring, impairment, and related charges 7 18
Non-cash charges (5)  
Cash payments (2)  
Other 0  
Ending balance 3  
Operating Segments | Medical-Surgical Solutions    
Restructuring Reserve [Roll Forward]    
Beginning balance 1  
Restructuring, impairment, and related charges 1 6
Non-cash charges 0  
Cash payments (1)  
Other 0  
Ending balance 1  
Operating Segments | International    
Restructuring Reserve [Roll Forward]    
Beginning balance 56  
Restructuring, impairment, and related charges 2 60
Non-cash charges 0  
Cash payments (2)  
Other (15)  
Ending balance 41  
Corporate    
Restructuring Reserve [Roll Forward]    
Beginning balance 59  
Restructuring, impairment, and related charges 9 $ 62
Non-cash charges 5  
Cash payments (15)  
Other 1  
Ending balance 59  
Other Current Liabilities    
Restructuring Reserve [Roll Forward]    
Beginning balance 58  
Ending balance 62  
Liabilities held for sale    
Restructuring Reserve [Roll Forward]    
Beginning balance 36  
Ending balance 26  
Other accrued liabilities, noncurrent    
Restructuring Reserve [Roll Forward]    
Beginning balance 36  
Ending balance $ 28